DRUG

ajmalin

1 hypothesis across 1 therapeutic domain

ALL HYPOTHESES

Repurposing candidates for ajmalin

Glioblastoma 1

Mediator Outcome Score Tier Lit. status Trial
mTOR glioblastoma 0.208 Mid novel signal none

Clinical trials

9 registered trials for ajmalin

Source: ClinicalTrials.gov